G. Demir Et Al. , "Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma," INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3, pp.163-168, 1998
Demir, G. Et Al. 1998. Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma. INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3 , 163-168.
Demir, G., Demirelli, F., Ozguroglu, M., Molinas-Mandel, N., Buyukunal, E., Tuzuner, N., ... Serdengecti, S.(1998). Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma. INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3, 163-168.
Demir, G Et Al. "Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma," INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3, 163-168, 1998
Demir, G Et Al. "Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma." INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3, pp.163-168, 1998
Demir, G. Et Al. (1998) . "Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma." INTERNATIONAL JOURNAL OF IMMUNOTHERAPY , vol.14, no.3, pp.163-168.
@article{article, author={G Demir Et Al. }, title={Immune effects of low-dose subcutaneous interleukin-2 in patients with metastatic malignant melanoma}, journal={INTERNATIONAL JOURNAL OF IMMUNOTHERAPY}, year=1998, pages={163-168} }